PubRank

Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27590194)

Published in Pathology on August 30, 2016

Authors

Laveniya Satgunaseelan1, Ruta Gupta2, Jason Madore3, Noel Chia4, Trina Lum1, Carsten E Palme5, Michael Boyer6, Richard A Scolyer7, Jonathan R Clark8

Author Affiliations

1: Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
2: Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. Electronic address: Ruta.Gupta@sswahs.nsw.gov.au.
3: Sydney Medical School, The University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia.
4: South West Clinical School, University of New South Wales, Sydney, Australia.
5: Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia.
6: Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia.
7: Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia.
8: Sydney Medical School, The University of Sydney, Sydney, Australia; South West Clinical School, University of New South Wales, Sydney, Australia; Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia.

Articles citing this ↘

Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis. PLoS One (2017) 0.75

Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy. Oncoimmunology (2017) 0.75

Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma. Curr Oncol Rep (2017) 0.75

Articles by these authors ⇆

A geographical comparison of p16 expression in squamous cell carcinoma (SCC) of the tongue. Pathology (2016) 0.75

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma. J Thorac Oncol (2017) 0.75

p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis. Pathology (2017) 0.75

PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma. Pathology (2017) 0.75